QQQ   431.67 (-1.51%)
AAPL   173.14 (-1.93%)
MSFT   414.37 (-1.78%)
META   499.79 (-2.37%)
GOOGL   155.00 (-1.73%)
AMZN   183.94 (-1.18%)
TSLA   162.12 (-5.22%)
NVDA   866.23 (-1.77%)
AMD   160.98 (-1.41%)
NIO   3.83 (-6.81%)
BABA   70.22 (-1.50%)
T   16.17 (-0.86%)
F   12.22 (-3.09%)
MU   120.91 (-1.31%)
GE   153.29 (-0.87%)
CGC   6.95 (-10.90%)
DIS   113.02 (-0.87%)
AMC   2.50 (-5.66%)
PFE   25.85 (-0.04%)
PYPL   63.43 (-1.80%)
XOM   119.69 (-0.56%)
QQQ   431.67 (-1.51%)
AAPL   173.14 (-1.93%)
MSFT   414.37 (-1.78%)
META   499.79 (-2.37%)
GOOGL   155.00 (-1.73%)
AMZN   183.94 (-1.18%)
TSLA   162.12 (-5.22%)
NVDA   866.23 (-1.77%)
AMD   160.98 (-1.41%)
NIO   3.83 (-6.81%)
BABA   70.22 (-1.50%)
T   16.17 (-0.86%)
F   12.22 (-3.09%)
MU   120.91 (-1.31%)
GE   153.29 (-0.87%)
CGC   6.95 (-10.90%)
DIS   113.02 (-0.87%)
AMC   2.50 (-5.66%)
PFE   25.85 (-0.04%)
PYPL   63.43 (-1.80%)
XOM   119.69 (-0.56%)
QQQ   431.67 (-1.51%)
AAPL   173.14 (-1.93%)
MSFT   414.37 (-1.78%)
META   499.79 (-2.37%)
GOOGL   155.00 (-1.73%)
AMZN   183.94 (-1.18%)
TSLA   162.12 (-5.22%)
NVDA   866.23 (-1.77%)
AMD   160.98 (-1.41%)
NIO   3.83 (-6.81%)
BABA   70.22 (-1.50%)
T   16.17 (-0.86%)
F   12.22 (-3.09%)
MU   120.91 (-1.31%)
GE   153.29 (-0.87%)
CGC   6.95 (-10.90%)
DIS   113.02 (-0.87%)
AMC   2.50 (-5.66%)
PFE   25.85 (-0.04%)
PYPL   63.43 (-1.80%)
XOM   119.69 (-0.56%)
QQQ   431.67 (-1.51%)
AAPL   173.14 (-1.93%)
MSFT   414.37 (-1.78%)
META   499.79 (-2.37%)
GOOGL   155.00 (-1.73%)
AMZN   183.94 (-1.18%)
TSLA   162.12 (-5.22%)
NVDA   866.23 (-1.77%)
AMD   160.98 (-1.41%)
NIO   3.83 (-6.81%)
BABA   70.22 (-1.50%)
T   16.17 (-0.86%)
F   12.22 (-3.09%)
MU   120.91 (-1.31%)
GE   153.29 (-0.87%)
CGC   6.95 (-10.90%)
DIS   113.02 (-0.87%)
AMC   2.50 (-5.66%)
PFE   25.85 (-0.04%)
PYPL   63.43 (-1.80%)
XOM   119.69 (-0.56%)

Mereo BioPharma Group (MREO) SEC Filings & 10K Form

$2.65
-0.07 (-2.57%)
(As of 03:09 PM ET)

Recent Mereo BioPharma Group SEC Filings

DateFilerForm TypeView
03/27/2024
4:20 PM
Mereo BioPharma Group (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2024
5:51 PM
Mereo BioPharma Group (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13G/A
02/14/2024
1:11 PM
Mereo BioPharma Group (Subject)
Rock Springs Capital Management LP (Filed by)
Form SC 13G/A
02/14/2024
11:36 AM
MANGROVE PARTNERS IM, LLC (Filed by)
Mereo BioPharma Group (Subject)
Form SC 13G
02/13/2024
4:26 PM
Mereo BioPharma Group (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
Form SC 13G/A
02/05/2024
4:09 PM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Mereo BioPharma Group (Subject)
Form SC 13G
01/23/2024
3:16 PM
Mereo BioPharma Group (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/08/2024
6:08 AM
Mereo BioPharma Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2024
3:16 PM
Hughes-Wilson Alexandra (Reporting)
Mereo BioPharma Group (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
3:17 PM
Mereo BioPharma Group (Issuer)
Shames Daniel (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
3:18 PM
Mereo BioPharma Group (Issuer)
Sermon Charles (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
3:15 PM
Bender Jeremy (Reporting)
Mereo BioPharma Group (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
3:15 PM
Mereo BioPharma Group (Issuer)
Roberts Justin Hunter (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
3:15 PM
Mereo BioPharma Group (Issuer)
Yoskowitz Marc J (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
3:15 PM
Jacquet Pierre (Reporting)
Mereo BioPharma Group (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
3:15 PM
Mereo BioPharma Group (Issuer)
WYZGA MICHAEL S (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
3:15 PM
Mereo BioPharma Group (Issuer)
Scots-Knight Denise (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
3:15 PM
Lewicki John A. (Reporting)
Mereo BioPharma Group (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
3:15 PM
Jenkins Annalisa (Reporting)
Mereo BioPharma Group (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
3:15 PM
Fox Chrisitne Ann (Reporting)
Mereo BioPharma Group (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
3:16 PM
Mereo BioPharma Group (Issuer)
PAKIANATHAN DEEPIKA (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/18/2023
3:16 PM
Mereo BioPharma Group (Filer)
Form 8-A12B/A
11/29/2023
3:15 PM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/20/2023
7:45 AM
Mereo BioPharma Group (Subject)
Rubric Capital Management LP (Filed by)
Form SC 13D/A
11/16/2023
6:01 AM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/15/2023
6:56 AM
Mereo BioPharma Group (Subject)
Rubric Capital Management LP (Filed by)
Form SC 13D/A
11/13/2023
6:31 AM
Mereo BioPharma Group (Subject)
Rubric Capital Management LP (Filed by)
Form SC 13D/A
11/08/2023
6:06 AM
Mereo BioPharma Group (Subject)
Rubric Capital Management LP (Filed by)
Form SC 13D/A
11/06/2023
6:30 AM
Mereo BioPharma Group (Subject)
Rubric Capital Management LP (Filed by)
Form SC 13D/A
11/02/2023
6:30 AM
Mereo BioPharma Group (Subject)
Rubric Capital Management LP (Filed by)
Form SC 13D/A
10/23/2023
3:08 PM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/17/2023
6:01 AM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/20/2023
3:03 PM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/07/2023
6:37 AM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/06/2023
7:05 AM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/16/2023
7:00 AM
Mereo BioPharma Group (Subject)
Rubric Capital Management LP (Filed by)
Form SC 13D/A
06/07/2023
7:41 AM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/22/2023
3:15 PM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:MREO) was last updated on 4/15/2024 by MarketBeat.com Staff

From Our Partners